{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:00:20Z","timestamp":1780491620240,"version":"3.54.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T00:00:00Z","timestamp":1407369600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0104480","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T18:21:41Z","timestamp":1407435701000},"page":"e104480","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis"],"prefix":"10.1371","volume":"9","author":[{"given":"Peijie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngalei","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,8,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/S0140-6736(03)15108-2","article-title":"Viral hepatitis B","volume":"362","author":"CL Lai","year":"2003","journal-title":"Lancet"},{"key":"ref2","first-page":"177","article-title":"[Liver transplantation\u2013indications, surgical technique, results\u2013the analysis of a clinical series of 200 cases]","volume":"105","author":"I Popescu","year":"2010","journal-title":"Chirurgia (Bucur)"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00007890-199104000-00011","article-title":"Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation","volume":"51","author":"RB Freeman","year":"1991","journal-title":"Transplantation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications","volume":"14","author":"JG O'Grady","year":"1992","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S1590-8658(09)60442-4","article-title":"The option of liver transplantation for hepatitis B: where are we","volume":"41","author":"D Samuel","year":"2009","journal-title":"Dig Liver Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJM198910123211505","article-title":"Liver transplantation (1)","volume":"321","author":"TE Starzl","year":"1989","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.TP.0000047027.68167.07","article-title":"Prophylaxis and treatment of recurrent hepatitis B after liver transplantation","volume":"75","author":"CM Lo","year":"2003","journal-title":"Transplantation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1053\/gast.2000.19279","article-title":"Successful orthotopic liver transplantation for lamivudine-associated YMDD mutant hepatitis B virus","volume":"119","author":"S Saab","year":"2000","journal-title":"Gastroenterology"},{"key":"ref9","first-page":"1810","article-title":"[Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]","volume":"28","author":"Y Yang","year":"2008","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1034\/j.1399-3062.2002.01012.x","article-title":"Evolving experience of hepatitis B virus prophylaxis in liver transplantation","volume":"4","author":"MR Honaker","year":"2002","journal-title":"Transpl Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1432-2277.2011.01236.x","article-title":"Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage","volume":"24","author":"GN Brock","year":"2011","journal-title":"Transpl Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/TP.0b013e31816a342a","article-title":"Viral persistence after liver transplantation for hepatitis B virus: a cross-sectional study","volume":"85","author":"DA Freshwater","year":"2008","journal-title":"Transplantation"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1432-2277.2008.00784.x","article-title":"Lamivudine or lamivudine combined with hepatitis B immunoglobulin in prophylaxis of hepatitis B recurrence after liver transplantation: a meta-analysis","volume":"22","author":"W Rao","year":"2009","journal-title":"Transpl Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1586\/eri.09.2","article-title":"Hepatitis B immunoglobulin in preventing reinfection following liver transplantation","volume":"7","author":"M Yamamoto","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.gastro.2011.06.083","article-title":"Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation","volume":"141","author":"J Fung","year":"2011","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"L Grellier","year":"1996","journal-title":"Lancet"},{"key":"ref17","first-page":"33","article-title":"Multicenter studies of Lamivudine for the treatment and prevention of hepatitis B after liver transplantation","volume":"1","author":"R Perrillo","year":"1999","journal-title":"Ochsner J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jcv.2013.06.035","article-title":"Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective","volume":"58","author":"DJ Wesdorp","year":"2013","journal-title":"J Clin Virol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ajg.2013.111","article-title":"Oral nucleoside\/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B","volume":"108","author":"J Fung","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"K Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.tp.0000277289.23677.0a","article-title":"Adherence to Lamivudine after an early withdrawal of hepatitis B immune globulin plays an important role in the long-term prevention of hepatitis B virus recurrence","volume":"84","author":"M Buti","year":"2007","journal-title":"Transplantation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1499-3872(13)60024-7","article-title":"HBV recurrence lowered by lamivudine\/HBIG combination therapy in liver transplant patients: ten-year experience","volume":"12","author":"CH Yuan","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/lt.20416","article-title":"Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine","volume":"11","author":"CM Lo","year":"2005","journal-title":"Liver Transpl"},{"key":"ref24","first-page":"106","article-title":"[Long-term prevention of virus recurrence among recipients with HBV active replication following liver transplantation]","volume":"15","author":"J Dai","year":"2009","journal-title":"CHINESE JOURNAL OF HEPATOBILIARY SURGERY"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00000658-200205000-00002","article-title":"New era of liver transplantation for hepatitis B: a 17-year single-center experience","volume":"235","author":"DM Anselmo","year":"2002","journal-title":"Ann Surg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.23628","article-title":"Randomized trial of emtricitabine\/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation","volume":"19","author":"LW Teperman","year":"2013","journal-title":"Liver Transpl"},{"key":"ref27","first-page":"1209","article-title":"Prevention and management of hepatitis B virus reinfection after liver transplantation","volume":"47","author":"MA Yi","year":"2009","journal-title":"CHINESE JOURNAL OF SURGERY"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/hep.22524","article-title":"A randomized study of adefovir dipivoxil in place of HBIG in combination with lamivudine as post-liver transplantation hepatitis B prophylaxis","volume":"48","author":"PW Angus","year":"2008","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/lt.20701","article-title":"Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis","volume":"12","author":"S Zheng","year":"2006","journal-title":"Liver Transpl"},{"key":"ref30","first-page":"348","article-title":"[Prevention and treatment of HBV reinfection after liver transplantation]","volume":"6","author":"X Jie","year":"2007","journal-title":"CHINESE JOURNAL OF DIGESTIVE SURGERY"},{"key":"ref31","first-page":"1288","article-title":"[Low-dose intra-muscular hepatitis B immunoglobulin combined with lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation]","volume":"14","author":"N Xia","year":"2006","journal-title":"WORLD CHINESE JOURNAL OF DIGESTOLOGY"},{"key":"ref32","first-page":"53","article-title":"[Low-dose hepatitis B immunoglobulin with Lamivudine in prophylaxis of hepatitis B recurrence after liver transplantation]","volume":"25","author":"X Qiang","year":"2004","journal-title":"CHINESE JOURNAL OF ORGAN TRANSPLANTATION"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1399-0012.2006.00557.x","article-title":"Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection","volume":"21","author":"H Yoshida","year":"2007","journal-title":"Clin Transplant"},{"key":"ref34","first-page":"14","article-title":"[Prevention and treatment of HBV reinfection following liver transplantation]","volume":"10","author":"G Yuan","year":"2002","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.transproceed.2007.03.062","article-title":"Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen","volume":"39","author":"ZY Jiao","year":"2007","journal-title":"Transplant Proc"},{"key":"ref36","first-page":"500","article-title":"Prevention and treatment of hepatitis B recurrence after liver transplantation","volume":"2","author":"JP Zhu","year":"2003","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/lt.20981","article-title":"Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results","volume":"13","author":"E Schiff","year":"2007","journal-title":"Liver Transpl"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.20277","article-title":"Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade","volume":"10","author":"GW Neff","year":"2004","journal-title":"Liver Transpl"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.21998","article-title":"Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review","volume":"16","author":"S Saab","year":"2010","journal-title":"Liver Transpl"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1499-3872(13)60074-0","article-title":"Prevention of recurrent hepatitis B infection after liver transplantation","volume":"12","author":"TC Wong","year":"2013","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1399-3062.2012.00741.x","article-title":"Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation","volume":"14","author":"E Cholongitas","year":"2012","journal-title":"Transpl Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0104480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:41:00Z","timestamp":1598143260000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0104480"}},"subtitle":[],"editor":[{"given":"James","family":"Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,8,7]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,8,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0104480","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,7]]}}}